Search Results - Edenhofer, Simone

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut by Huber, Henriette (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Edenhofer, Simone (Author) , Tresckow, Julia von (Author) , Robrecht, Sandra (Author) , Giza, Adam (Author) , Zhang, Can (Author) , Fürstenau, Moritz (Author) , Dreger, Peter (Author) , Ritgen, Matthias (Author) , Illmer, Thomas (Author) , Illert, Anna Lena (Author) , Dürig, Jan (Author) , Böttcher, Sebastian (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia by Huber, Henriette (Author) , Edenhofer, Simone (Author) , von Tresckow, Julia (Author) , Robrecht, Sandra (Author) , Zhang, Can (Author) , Tausch, Eugen (Author) , Schneider, Christof (Author) , Bloehdorn, Johannes (Author) , Fürstenau, Moritz (Author) , Dreger, Peter (Author) , Ritgen, Matthias (Author) , Illmer, Thomas (Author) , Illert, Anna L. (Author) , Dürig, Jan (Author) , Böttcher, Sebastian (Author) , Niemann, Carsten U. (Author) , Kneba, Michael (Author) , Fink, Anna-Maria (Author) , Fischer, Kirsten (Author) , Döhner, Hartmut (Author) , Hallek, Michael (Author) , Eichhorst, Barbara (Author) , Stilgenbauer, Stephan (Author) ,


    Get full text
    Article (Journal) Online Resource